Oxford Malaria vaccine proves highly effective in Burkina Faso trial

Vaccine developed by scientists at Jenner Institute, Oxford, shows up to 77% efficacy in trial over 12 months

A vaccine against malaria has been shown to be highly effective in trials in Africa, holding out the real possibility of slashing the death toll of a disease that kills 400,000 mostly small children every year.

The vaccine, developed by scientists at the Jenner Institute of Oxford University, showed up to 77% efficacy in a trial of 450 children in Burkina Faso over 12 months.